Status
Reexamination Certificate Issued
Requester
Requester Law Firm
Requested By
Third Party
Patent OwnerInferred
P.O. Law Firm
Reexam History (45 events)
Oct 15, 2025REEXInput Issue Number and Issue Date for Reexamination
Sep 30, 2025RXPUBSReexam Forwarded to Office of Publications
Aug 29, 2025MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Aug 19, 2025RXRLFReExam Litigation Found
Aug 19, 2025RXLITSRReexam Litigation Search Conducted
Aug 19, 2025IDSCInformation Disclosure Statement considered
Jul 30, 2025WIDSInformation Disclosure Statement (IDS) Filed
Jul 30, 2025RXLET.Miscellaneous Incoming Letter
Jul 30, 2025RXIDS.Information Disclosure Statement Filed
Jul 30, 2025RXC/SRCertificate of Service
Jul 30, 2025RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Jul 30, 2025RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Jul 30, 2025RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Jul 30, 2025RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Jul 30, 2025RXA...Response after Non-Final Action
Jul 30, 2025RCCPRX - Concurrent Proceedings Notice
Jun 24, 2025MRXG.RX - Mail Extension of Time Period for Response Granted
Jun 17, 2025RXRQ/TRequest for Extension of Time
Jun 17, 2025RXC/SRCertificate of Service
Jun 13, 2025MREXNRX - Mail Examiner Interview Summary Record
Apr 30, 2025MR.NFRX - Mail Reexam Non-Final Action
Apr 2, 2025RXFWDXDate Forwarded to Examiner
Feb 4, 2025MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Jan 28, 2025MREXORX - Mail Ex Parte Request for Reexamination Granted
Jan 13, 2025RXRLFReExam Litigation Found
Jan 13, 2025RXLITSRReexam Litigation Search Conducted
Dec 21, 2024IDSCInformation Disclosure Statement considered
Dec 21, 2024IDSCInformation Disclosure Statement considered
Dec 20, 2024MRXNReexamination Formalities Notice Mailed
Dec 20, 2024MRXNReexamination Formalities Notice Mailed
Dec 20, 2024COMPApplication Is Now Complete
Dec 19, 2024RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Dec 19, 2024RXNREQFDNotice of reexamination request filing date
Dec 19, 2024RXNREQAUNotice of assignment of reexamination request
Dec 19, 2024FTFIFITF set to NO - revise initial setting
Dec 19, 2024DOCKCase Docketed to Examiner in GAU
Dec 17, 2024SMALApplicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
Dec 17, 2024RXTTLRPTTitle Report
Dec 16, 2024WIDSInformation Disclosure Statement (IDS) Filed
Dec 16, 2024WIDSInformation Disclosure Statement (IDS) Filed
Dec 16, 2024RXOSUB.RReexamination requested by third party requester
Dec 16, 2024RXOSUBReceipt of Original Ex Parte Reexam Request
Dec 16, 2024RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Dec 16, 2024RXC/SRCertificate of Service
Dec 16, 2024BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
Prosecution, PTAB & CAFC
PTAB Proceedings (IPR, PGR, CBM, DER)
IPR2025-00514IPR — Discretionary Denial
Petitioner
Apotex Inc. et al.
Petition Filed
Jan 30, 2025
Institution
Jul 2, 2025
Decision
Jul 2, 2025
Terminated
Jul 2, 2025
IPR2018-00943IPR — Terminated-Settled
Petitioner
Amneal Pharmaceuticals LLC
Petition Filed
Apr 20, 2018
Institution
Nov 7, 2018
Terminated
Jul 31, 2019
Federal Circuit (CAFC)
None found
Terminal Disclaimer
None found
Prosecution History
None found
Maintenance Fees
Grant
Apr 5, 2011
3.5-yr
Oct 5, 2014
7.5-yr
Oct 5, 2018
Paid Oct 5, 2018
11.5-yr
Oct 5, 2022
Paid Oct 5, 2022
Expiry
Oct 15, 2029
Entity Status
Large Entity
Expires
Oct 15, 2029 (3.6 yr remaining)
Term Adjustment
+1673 days (~4.6 yr)
Assignments
AssignmentReel/Frame: 016532/0118Recorded: Jul 15, 2005
From
ELLIOT EHRICHInventor
Jun 14, 2005
→
To
ALKERMES CONTROLLED THERAPEUTICS, II
MergerReel/Frame: 020035/0827Recorded: Oct 31, 2007
From
ALKERMES CONTROLLED THERAPEUTICS, II
Jul 26, 2006
→
To
ALKERMES, INC.
Security InterestReel/Frame: 026994/0245Recorded: Sep 29, 2011
From
ALKERMES CONTROLLED THERAPEUTICS INC.
Sep 16, 2011
ALKERMES PHARMA IRELAND LIMITED
Sep 16, 2011
ALKERMES, INC.
Sep 16, 2011
→
To
MORGAN STANLEY SENIOR FUNDING, INC.
Security InterestReel/Frame: 026994/0186Recorded: Sep 29, 2011
From
ALKERMES CONTROLLED THERAPEUTICS INC.
Sep 16, 2011
ALKERMES PHARMA IRELAND LIMITED
Sep 16, 2011
ALKERMES, INC.
Sep 16, 2011
→
To
MORGAN STANLEY SENIOR FUNDING, INC.
ReleaseReel/Frame: 029116/0379Recorded: Oct 12, 2012
From
MORGAN STANLEY SENIOR FUNDING, INC.
Sep 24, 2012
→
To
ALKERMES, INC.
AssignmentReel/Frame: 036809/0447Recorded: Oct 16, 2015
From
ALKERMES, INC.
Oct 16, 2015
→
To
ALKERMES PHARMA IRELAND LIMITED
ReleaseReel/Frame: 069771/0548Recorded: Dec 24, 2024
From
MORGAN STANLEY SENIOR FUNDING, INC.
Dec 19, 2024
→
To
ALKERMES, INC.
Security InterestReel/Frame: 073213/0302Recorded: Oct 23, 2025
From
ALKERMES PHARMA IRELAND LIMITED
Oct 22, 2025
→
To
JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT